Keyphrases
Metastatic Melanoma
100%
Immunohistochemical Findings
100%
Primary Dermal Melanoma
100%
Clinical Outcomes
100%
Nodular Melanoma
100%
Melanoma
42%
Cyclin D1 (CCND1)
28%
Ki-67
28%
D2-40
28%
Cutaneous Metastatic Melanoma
28%
Patient Assessment
14%
Medical Center
14%
Imaging Studies
14%
Clinical Features
14%
Clinical Assessment
14%
Cohort Analysis
14%
Pathological Examination
14%
Survival Rate
14%
Nevus
14%
Pathology Department
14%
MIB1
14%
Prolonged Survival
14%
Liver Metastasis
14%
Cyclin D2 (CCND2)
14%
Clinical History
14%
Pulmonary Metastasis
14%
Long-term Clinical Outcome
14%
Sentinel Lymph Node Biopsy
14%
Podoplanin
14%
Skin Examination
14%
Subcutaneous Nodules
14%
Breslow Depth
14%
Dermal Nodules
14%
Melanoma Subtypes
14%
Melanoma-specific Survival
14%
Immunohistochemical Panel
14%
In-transit Recurrence
14%
Immunohistochemical Assessment
14%
Lymphovascular
14%
In Situ Component
14%
Immunohistochemical Features
14%
Medicine and Dentistry
Metastatic Melanoma
100%
Nodular Melanoma
100%
Protein P53
11%
Cohort Analysis
11%
Cyclin D1
11%
Venous Ulcer
5%
Recurrent Disease
5%
Nevus Sebaceous
5%
Survival Rate
5%
Cyclin D2
5%
Liver Metastasis
5%
Clinical Intervention
5%
Sentinel Lymph Node Biopsy
5%
Lung Metastasis
5%
Lymph Duct
5%
Podoplanin
5%
Skin Examination
5%
Breslow's Depth
5%
Subcutaneous Nodule
5%